IL-6R — Drug Target

All drugs that target IL-6R — marketed and clinical-stage. Includes 2 drug classes acting on this target.

Drug classes

IL-6 receptor antagonist · Biologic DMARD

Phase 3 pipeline (7)

• Tocilizumab treatment · Centre Hospitalier Universitaire Dijon · IL-6 receptor antagonist · Immunology
  Tocilizumab is an interleukin-6 receptor antagonist that inhibits the inflammatory response by blocking the action of interleukin-6.
• Tociliziumab group · Biogipuzkoa Health Research Institute · IL-6 receptor antagonist · Immunology
  Tocilizumab is an interleukin-6 receptor antagonist that inhibits the inflammatory response.
• placebo to tocilizumab IV · Hoffmann-La Roche · IL-6 receptor antagonist · Immunology
  Tocilizumab is an interleukin-6 receptor antagonist that inhibits the inflammatory response by blocking the action of interleukin-6.
• tocilizumab SC · Hoffmann-La Roche · IL-6 receptor antagonist · Immunology
  Tocilizumab SC is an interleukin-6 receptor antagonist that blocks the action of interleukin-6, a cytokine involved in inflammation.
• placebo to tocilizumab SC · Hoffmann-La Roche · IL-6 receptor antagonist · Immunology
  Tocilizumab is an interleukin-6 receptor antagonist that inhibits the inflammatory response by blocking the action of interleukin-6.
• Tocilizumab Injection · Abderrahmane Mami Hospital · IL-6 receptor antagonist · Immunology
  Tocilizumab Injection is an interleukin-6 receptor antagonist that blocks the action of interleukin-6, a cytokine involved in inflammation.
• Tocilizumab Prefilled Syringe [Actemra] · Medical University of Vienna · IL-6 receptor antagonist · Immunology
  Tocilizumab is an interleukin-6 receptor antagonist that inhibits the inflammatory response by blocking the action of interleukin-6.

Phase 2 pipeline (1)

• DMARDs or Biologics · Pfizer · Biologic DMARD · Rheumatology
  T-cell co-stimulation inhibitor